Expion Energy Stock Soars 60% as Fundraising Nearly Matches Market Cap
Markets Daniel Marsh

Expion Energy Stock Soars 60% as Fundraising Nearly Matches Market Cap

Expion Energy (XPON) shares jumped 60% after raising $8.2 million, nearly matching its market cap. The battery firm is pivoting to Louisiana gas exploration.

XPON
Mitsubishi Motors Rally on Pajero Comeback Plans
Markets Daniel Marsh

Mitsubishi Motors Rally on Pajero Comeback Plans

Mitsubishi Motors shares gained 2.5% as investors anticipate the September 2 global debut of the 2027 Pajero, a key model for the company's sales and profit targets.

Biohaven Stock Soars 25% on Trade Secret Ruling
Markets Daniel Marsh

Biohaven Stock Soars 25% on Trade Secret Ruling

Biohaven shares surged 25% after a federal court finalized a $4 million trade secret ruling, boosting market cap by $553 million as investors bet on platform value.

BHVN
MG Hector Tomahawk EV and PHEV Launch in India; SAIC Expands Market Presence
Markets Daniel Marsh

MG Hector Tomahawk EV and PHEV Launch in India; SAIC Expands Market Presence

MG Hector Tomahawk EV starts at ₹1.95 million, with battery rental reducing entry price. PHEV variant offers 1,100 km range. SAIC shares rise 0.78%.

SAIC
Loblaw Revives Tariff Tags, Highlights Margin Sensitivity
Analysis Daniel Marsh

Loblaw Revives Tariff Tags, Highlights Margin Sensitivity

Loblaw brings back 'T' tariff labels on shelves as trade friction widens, with CEO Per Bank noting stronger supply chain diversification.

L
Asia Chip Stocks Pare Losses as KASE Global Wraps Up; PCE Inflation Pressures Fed Bets
Markets Daniel Marsh

Asia Chip Stocks Pare Losses as KASE Global Wraps Up; PCE Inflation Pressures Fed Bets

Asian chip stocks narrowed losses as KASE Global entered its final hour, while a hotter-than-expected US PCE inflation report lifted Fed hike odds and pressured rate-sensitive growth stocks.

NVDA AMD INTC META COP TSM
FDA Approves Rasonque, Revolution Medicines Stock Holds Steady
Analysis Daniel Marsh

FDA Approves Rasonque, Revolution Medicines Stock Holds Steady

Revolution Medicines (RVMD) received FDA approval for Rasonque in pancreatic cancer, but shares rose only 0.8% as investors awaited launch details.

RVMD
Target Stock Rebounds After Costume Controversy Erases $2.9B
Markets Daniel Marsh

Target Stock Rebounds After Costume Controversy Erases $2.9B

Target (TGT) shares edged up 0.6% Wednesday, recovering from a $2.9B market value loss triggered by a controversial Halloween costume. Analysts remain cautious.

TGT WMT COST
Qantas Doubles Loyalty Rewards in 8-Day Push Ahead of FY Results
Earnings James Calloway

Qantas Doubles Loyalty Rewards in 8-Day Push Ahead of FY Results

Qantas launches an 8-day double rewards promotion for its 18.3 million loyalty members, with Loyalty EBIT up 12% to A$286 million. Stock slips 0.32% ahead of Thursday's earnings.

SolarEdge Jumps on UBS Upgrade, FCC Rule Seen Boosting Pricing Power
Markets Daniel Marsh

SolarEdge Jumps on UBS Upgrade, FCC Rule Seen Boosting Pricing Power

SolarEdge shares climbed 7.7% after UBS upgraded the stock to Buy and raised its price target to $42, citing FCC inverter restrictions that could boost pricing power.

SEDG
Apple's Mac mini M6 Launch Lifts Shares 1.1% Despite Higher Price
Technology Sarah Chen

Apple's Mac mini M6 Launch Lifts Shares 1.1% Despite Higher Price

Apple (AAPL) shares gained 1.1% following the Mac mini M6 launch, priced at $899 (up 12.5%). The company's Mac division posted record revenue of $10.4 billion last quarter.

AAPL
McDonald's McGold Card Campaign Launches in Australia with Daily App Deals
Analysis Daniel Marsh

McDonald's McGold Card Campaign Launches in Australia with Daily App Deals

McDonald's launches its Australian McGold Card campaign with 30 daily app deals and nine lifetime prizes worth A$561,600. MCD shares slipped 0.39%.

MCD